Biosystems International (BSI) is an in-vitro diagnostics research and development company. It deploys a protected protein epitome profiling technology platform for the discovery and development of disease-specific plasma protein epitope panels (multivariate index assays). The company also offers special laboratory services using its mAb proteomics technologies.